|
1240561000000108 | Encephalopathy due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
840546002 | Exposure to Severe acute respiratory syndrome coronavirus 2 (event) | Z20.8 | Contact with and exposure to other communicable disease |
| 20200309 |
119751000146104 | Fever caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
1240541000000107 | Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
880529761000119102 | Lower respiratory infection caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
866151004 | Lymphocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
1240531000000103 | Myocarditis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
897036007 | Occupational exposure to Severe acute respiratory syndrome coronavirus 2 (event) | Z20.8 | Contact with and exposure to other communicable disease |
| 20210131 |
1240521000000100 | Otitis media due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
882784691000119100 | Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
1119303003 | Post-acute COVID-19 (disorder) | U09.9 | Post COVID-19 condition, unspecified |
| 20210131 |
870591003 | Rhabdomyolysis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
870588003 | Sepsis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
1240581000000104 | Severe acute respiratory syndrome coronavirus 2 detected (finding) | U07.1 | COVID-19, virus identified |
| 20200731 |
866152006 | Thrombocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
1017214008 | Viremia caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |